Christopher C. Richard's most recent trade in Lexaria Bioscience Corp was a trade of 27,172 common shares done at an average price of $2.5 . Disclosure was reported to the exchange on Dec. 2, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lexaria Bioscience Corp | Christopher Richard C. | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.47 per share. | 02 Dec 2024 | 27,172 | 50,000 | - | 2.5 | 67,175 | common shares |
Lexaria Bioscience Corp | Christopher C. Richard | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 02 Dec 2024 | 22,828 | 22,828 | - | 2.2 | 51,217 | common shares |
InVivo Therapeutics Holdin... | Richard C. Christopher | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 20,800 | 20,800 | - | - | Stock Option (right to buy) | |
InVivo Therapeutics Holdin... | Richard C. Christopher | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) |